Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Cited by (1,001)

Items 601–700 of 1,001

1. Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy
   Luca Cantini, Lucia Bastianelli, Alessio Lupi, Giada Pinterpe, Federica Pecci, Giovanni Belletti, Rosa Stoico, Francesca Vitarelli, Marco Moretti, Nicoletta Onori et al. · 2021 · Journal of Clinical Medicine
2. Satisfaction among Cancer Patients Undergoing Radiotherapy during the COVID-19 Pandemic: An Institutional Experience
   Vanessa Di Lalla, Haley M. Patrick, Nicolas Siriani-Ayoub, J. Kildea, Tarek Hijal, Joanne Alfieri · 2021 · Current Oncology
3. Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
   Cynthia L. Bowes, Vivek Naranbhai, Kerri St. Denis, Evan Christopher Lam, Brittany Bertaux, Florence K. Keane, Melin Janardan Khandekar, Alejandro Benjamin Balazs, John Iafrate, Justin F. Gainor et al. · 2021 · Radiotherapy and Oncology
4. Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer
   Ruoding Tan, Cindy Yun, Arpamas Seetasith, Daniel M. Sheinson, Robert Walls, Innocent Ngwa, Josina C. Reddy, Qing Hua Zhang, Matthew H. Secrest, Peter Lambert et al. · 2022 · The Oncologist
5. Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
   Waqar Ahmad, Khadija Shabbiri · 2022 · The Egyptian Journal of Internal Medicine
6. Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review
   Mohammad Ali, Shahid Ud Din Wani, Mubashir Hussain Masoodi, Nisar Ahmad Khan, Hosakote Gurumallappa Shivakumar, Riyaz Ali M. Osmani, Khalid Ahmed Khan · 2022 · Clinical Complementary Medicine and Pharmacology
7. Telemedicine in lung cancer during COVID-19 outbreak: A scoping review
   Ali Garavand, Nasim Aslani, Ali Behmanesh, Roshanak Shams · 2022 · Journal of Education and Health Promotion
8. COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination
   Maxwell Salvatore, Miriam M. Hu, Lauren J. Beesley, Alison M. Mondul, Celeste Leigh Pearce, Christopher Ryan Friese, Lars G. Fritsche, Bhramar Mukherjee · 2023 · Cancer Epidemiology Biomarkers & Prevention
9. Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer
   Marco Tagliamento, Alessandra Gennari, Matteo Lambertini, Ramón Salazar, Nadia Harbeck, Lucia Del Mastro, Mark Bower, Rachel J. Sharkey, Alessia Dalla Pria, Andrea Plaja et al. · 2023 · Journal of Clinical Oncology
10. Influenza vaccination and COVID-19 infection risk and disease severity: A systematic review and multilevel meta-analysis of prospective studies
    Marco Del Riccio, Saverio Caini, Guglielmo Bonaccorsi, Chiara Lorini, John Paget, Koos van der Velden, Claudia Cosma · 2024 · American Journal of Infection Control
11. Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I—conceptual challenges
    Sergio Rutella, Michael A. Cannarile, Sacha Gnjatic, Bruno Gomes, Justin Guinney, Vaios Karanikas, Mohan Karkada, John M. Kirkwood, Beatrix Kotlán, Giuseppe Valentino Masucci et al. · 2020 · Journal for ImmunoTherapy of Cancer
12. The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
    Maciej M. Mrugała, Quinn T. Ostrom, Shelley M. Pressley, Jennie Webster Taylor, Alissa A. Thomas, Jeffrey Scott Wefel, Scott L. Coven, Alvina Acquaye, Chas Haynes, Sameer Agnihotri et al. · 2021 · Neuro-Oncology Advances
13. Socioeconomic Inequalities and Ethnicity Are Associated with a Positive COVID-19 Test among Cancer Patients in the UK Biobank Cohort
    Shing Fung Lee, Maja Nikšić, Bernard Rachet, María‐José Sánchez, Miguel Ángel Luque-Fernández · 2021 · Cancers
14. Clinical characteristics, risk factors, and cardiac manifestations of cancer patients with COVID-19
    Yan Huang, Zhenhong Hu, Dong Hu, Zhou Quan, Xiaoyang Zhou, Guohua Fan, Xiu Chen, Xiaoxiong Liu, Zhonghe Zhang, Ganxiao Chen et al. · 2021 · Journal of Applied Physiology
15. Impact of the COVID-19 Pandemic on Palliative Care in Cancer Patients in Spain
    Cristina María Beltrán-Aroca, Rafael Ruiz-Montero, Antonio Llergo Muñoz, Leticia Rubio, Eloy Girela-López · 2021 · International Journal of Environmental Research and Public Health
16. Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic
    Vladimir A. Ljubimov, Arshia Ramesh, Saya Davani, Moise Danielpour, Joshua J. Breunig, Keith L. Black · 2021 · Advanced Drug Delivery Reviews
17. Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells
    Lanlan Zhou, Kelsey E. Huntington, Shengliang Zhang, Lindsey Carlsen, Eui Young So, Cassandra Parker, İlyas Şahin, Howard P. Safran, Suchitra Kamle, Chang Min Lee et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
18. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 12)
    David Simons, Lion Shahab, Jamie Brown, Olga Perski · 2021
19. An Asian Perspective of the Management of COVID-19: the Asian National Cancer Centers Alliance Led Regional Comparison
    Luh Komang Mela Dewi, Laureline Gatellier, Kanaga Sabapathy, Conjeevaram S. Pramesh, Min Dai, Tran Thanh Huong, Murat Gültekin, Erdenekhuu Nansalmaa, Khin Khin Htwe, Muhammed Aasim Yusuf et al. · 2020 · Asian Pacific Journal of Cancer Care
20. SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study
    Manuel Zorzi, Stefano Guzzinati, Francesco Avossa, Ugo Fedeli, Arianna Calcinotto, Massimo Rugge · 2021 · Frontiers in Oncology
21. Association of SARS-CoV-2 cycle threshold (Ct) values with clinical course and serum biomarkers in COVID-19 patients
    İmran Sağlık, Beyza Ener, Halis Akalın, Buşra Ozdemir, Gökhan Ocakoğlu, Baris Yalcin, Uğur Önal, Özge Aydın Güçlü, Nilüfer Aylin Acet Öztürk, Nazmiye Ülkü Tüzemen et al. · 2022 · The Journal of Infection in Developing Countries
22. The impact of the COVID‐19 pandemic on alloplastic breast reconstruction: An analysis of national outcomes
    Sarah N. Chiang, Michael J. Finnan, Gary B. Skolnick, Justin Michael Sacks, Joani M. Christensen · 2022 · Journal of Surgical Oncology
23. Burnout, coping and resilience of the cancer care workforce during the SARS-CoV-2: A multinational cross-sectional study
    Constantina Cloconi, Mary Economou, Andreas Charalambous · 2022 · European Journal of Oncology Nursing
24. Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis
    Damian Mojsak, Michał Dębczyński, Beata Kuklińska, Łukasz Minarowski, Agnieszka Kasiukiewicz, Anna M. Moniuszko-Malinowska, Piotr Czupryna, Robert Marek Mróz · 2023 · International Journal of Environmental Research and Public Health
25. One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer
    Charlotte Louise Moss, Saoirse Olivia Dolly, Beth A. Russell, Mary Lei, Sharmista Ghosh, Sophie Papa, Richard J. Sullivan, Mieke Van Hemelrijck, Anne Sagar Rigg, on behalf of Guy’s Cancer Real World Evidence Programme · 2020 · Cancer Control
26. Pandemics and pathology: a reflection on influenza, HIV/AIDS and SARS (COVID-19) pandemic infections
    Sebastian B Lucas · 2020 · Diagnostic histopathology
27. Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
    Prakirthi Yerram, Jennifer Thackray, Lisa R. Modelevsky, Josiah D. Land, Samantha Reiss, Krisoula Spatz, Andréa LeVoir, Terry Pak, Phuong H. Dao, Michael J. Buege et al. · 2021 · Journal of Oncology Pharmacy Practice
28. IMPACT OF COVID-19 IN PATIENTS WITH CANCER: A SCOPING REVIEW
    Tâmara Taynah Medeiros da Silva, Naryllenne Maciel de Araújo, Sabrina Daiane Gurgel Sarmento, Grayce Louyse Tinôco de Castro, Daniele Vieira Dantas, Rodrigo Assis Neves Dantas · 2021 · Texto & Contexto - Enfermagem
29. Same day yttrium-90 radioembolization with single photon emission computed tomography/computed tomography: An opportunity to improve care during the COVID-19 pandemic and beyond
    Mohammad Elsayed, Mohammad Loya, James R. Galt, David M. Schuster, Zachary Louis Bercu, Janice M. Newsome, David C. Brandon, Sonia Benenati, Keywan Behbahani, Richard Duszak et al. · 2021 · World Journal of Gastrointestinal Oncology
30. Telehealth Amid the COVID-19 Pandemic: Perception Among Asian, Native Hawaiian and Pacific Islander Cancer Patients
    Michael Meno, Justin Abe, Jami Aya Fukui, Christa Braun‐Inglis, Ian Pagano, Jared David Acoba · 2021 · Future Oncology
31. Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China
    Jielin Wei, Mengjiao Wu, Jing Liu, Xu Wang, Peng‐Fei Xia, Ling Peng, Yu Huang, Cuiwei Liu, Zihan Xia, Chuang Chen et al. · 2021 · The Breast
32. COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study
    Julien Péron, Tristan Dagonneau, Anne Conrad, Fanny Pineau, Sara Calattini, Gilles Freyer, David Pérol, Christophe Sajous, Maël Heiblig · 2021 · Cancers
33. Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials
    Pamela Trillo Aliaga, Dario Trapani, José Luís Sandoval, Edoardo Crimini, Gabriele Antonarelli, Grazia Vivanet, Stefania Morganti, Chiara Corti, Paolo Tarantino, Alex Friedlaender et al. · 2021 · Cancers
34. The impact of COVID-19 on cancer care in a tertiary hospital in Korea: possible collateral damage to emergency care
    Shin Hye Yoo, Jin-Ah Sim, Jeongmi Shin, Bhumsuk Keam, Jun‐Bean Park, Aesun Shin · 2022 · Epidemiology and Health
35. Mortality in patients with cancer and SARS-CoV-2 infection: Results from the Argentinean Network of Hospital-Based Cancer Registries
    Gisel Lorena Fattore, Natalia Silvana Aráoz Olivos, José Enrique Carrizo Olalla, Lara Gomez, Agustina Flamenco Marucco, María Paz Rojas Mena · 2022 · Cancer Epidemiology
36. COVID ‐19 outcomes in children, adolescents and young adults with cancer
    Rebecca S Parker, Justin Le, Andrew Doan, Paibel Ixia Aguayo-Hiraldo, Pia S. Pannaraj, Teresa Rushing, Jemily Malvar, Maurice R.G. O’Gorman, Jennifer Dien Bard, Chintan Parekh · 2022 · International Journal of Cancer
37. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
    Chunye Zhang, Shuai Liu, Ming Jun Yang · 2022 · World Journal of Gastrointestinal Oncology
38. Immediate Postmastectomy Implant-Based Breast Reconstruction: An Outpatient Procedure?
    Alexandra M. Keane, Grace C. Keane, Gary B. Skolnick, David Chi, Trina G. Ebersole, Terence Michael Myckatyn, Marissa M.J. Tenenbaum · 2023 · Plastic & Reconstructive Surgery
39. Trends in maternal mental health during the COVID-19 pandemic–evidence from Zambia
    Irene Falgas‐Bagué, Thandiwe Tembo, Jeanette L. Kaiser, Davidson Howes Hamer, Nancy Scott, Thandiwe Ngoma, Ravi Paul, Allison Juntunen, Peter C. Rockers, Günther Fink · 2023 · PLoS ONE
40. Current challenges and perspectives in lung cancer care during COVID-19 waves
    Domenica Francesca Mariniello, Luigi Aronne, Maria Vitale, Angela Schiattarella, Raffaella Pagliaro, Klara Komici · 2023 · Current Opinion in Pulmonary Medicine
41. Time to SARS‐CoV‐2 clearance among patients with cancer and COVID‐19
    Wenxin Vincent Xu, Andrew J. Piper‐Vallillo, Poorva Bindal, Jonathan W. Wischhusen, Jaymin M. Patel, Daniel Botelho Costa, Mary Linton B. Peters · 2021 · Cancer Medicine
42. SARS‐CoV‐2 nosocomial infection: Real‐world results of environmental surface testing from a large tertiary cancer center
    Mansi R. Shah, Imraan Jan, Jeremy Johns, Kuldip Singh, Pallavi P. Kumar, Norma Belarmino, Kara Saggiomo, Carolyn Hayes, Kimyatta Washington, Deborah Toppmeyer et al. · 2021 · Cancer
43. Evidence for residual SARS-CoV-2 in glioblastoma tissue of a convalescent patient
    Jie Lei, Yueping Liu, Tianhao Xie, Guojie Yao, Gang Wang, Bo Diao, Jian Song · 2021 · Neuroreport
44. Clinical outcomes in cancer patients with COVID ‐19
    Amelia Sawyers, Margaret M. Chou, Paul M. Johannet, Nicholas Gulati, Yingzhi Qian, Judy Zhong, Iman Osman · 2021 · Cancer Reports
45. The SARS-CoV-2 Pandemic and Cancer Trials Ireland: Impact, Resolution and Legacy
    Séamus O’Reilly, Verena Murphy, Eibhlin Mulroe, Lisa Tucker, Fiona Carragher, Jacinta Marron, Aoife M. Shannon, Ken Rogan, Roisín M. Connolly, Bryan T. Hennessy et al. · 2022 · Cancers
46. Inflammatory leptomeningeal cytokines mediate delayed COVID-19 encephalopathy
    Ján Remšík, Jessica A. Wilcox, N. Esther Babady, Tracy A. McMillen, Behroze Adi Vachha, Neil A. Halpern, Vikram Dhawan, Marc K. Rosenblum, Christine A. Iacobuzio–Donahue, Edward K. Avila et al. · 2020 · medRxiv
47. Rate of COVID‐19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome‐coronavirus 2: Analysis of the American Society of Clinical Oncology Registry
    Dax Kurbegov, Suanna S. Bruinooge, Xiudong Jennifer Lei, M. Kelsey Kirkwood, Natalie R. Dickson, Trupti Hattiangadi, Kathryn Finch Mileham, Alicia L. Patrick, Jen Hanley Williams, Melinda W. Kaltenbaugh et al. · 2023 · Cancer
48. Linking COVID-19 and cancer: Underlying mechanism
    Sourabh Tyagi, Nipanshi Tyagi, Anu Singh, Akanksha Gautam, Awantika Singh, Shelja Jindal, Rana Pratap Singh, Rupesh Chaturvedi, Hemant Ritturaj Kushwaha · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
49. SARS-CoV-2/COVID-19: Systematischer Review zu Anforderungen an die persönliche Schutzausrüstung bei primärem Patientenkontakt und Strukturierung des Operationsbereiches
    Andreas Anton Schnitzbauer, Volkhard A. J. Kempf, Daniel Hack, Sandra Ciesek, Simon Lars Meier, Maria J. G. T. Vehreschild, Sabine Wicker, Ulf Kippke, Jürgen Graf, İngo Marzi · 2020 · Der Chirurg
50. Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?
    Jianping Bi, Hong Ma, Dongsheng Zhang, Jing Huang, Dongqin Yang, Yajie Wang, Vivek Verma, Tao� Zhang, Desheng Hu, Qi Mei et al. · 2020 · European Respiratory Journal
51. SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review
    Guilherme Haradaa, F. Antonacio, Aline B. L. Gongora, M. H. Behar, F. Capareli, D. Bastos, R. Munhoz, F. Costa, D. Jardim, Celso Arrais-Rodrigues et al. · 2020 · ecancermedicalscience
52. Revisión sobre obesidad como factor de riesgo para mortalidad por COVID-19
    Janeth Tenorio‐Mucha, Yamilée Hurtado-Roca · 2020 · ACTA MEDICA PERUANA
53. What Proportion of Patients with Bone and Soft Tissue Tumors Contracted Coronavirus-19 and Died From Surgical Procedures During the Initial Period of the COVID-19 Pandemic? Results From the Multicenter British Orthopaedic Oncology Society Observational Study
    Raja Bhaskara Rajasekaran, Robert U. Ashford, Thomas D. A. Cosker, Jonathan Daniel Stevenson, Lee Marcus Jeys, Rob C. Pollock, Kenneth Samora Rankin, Paul Cool, James T. Patton, Duncan Whitwell et al. · 2020 · Clinical Orthopaedics and Related Research
54. Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study
    Alexander Höllein, Peter Bojko, Sebastian Schulz, Julia S. Neitz, Oliver J. Stötzer, Rudolf Pihusch, Fariborz Abedinpour, Burkhard Schmidt, Marcus Hentrich · 2021 · Acta Oncologica
55. Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis
    Zhixian Lin, Jiangfeng Chen, Sunya Han · 2021 · Expert Review of Anticancer Therapy
56. The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials
    Amara Ndumele, Ko Un Park · 2021 · Current Breast Cancer Reports
57. Impact of COVID‐19 lockdown on routine oncology versus emergency care at a high volume cancer centre
    Christoph Minichsdorfer, Georg Jeryczynski, Christoph Krall, Alina Magdalena Achhorner, Ariane Caraan, Sabina Pasalic, Katharina Reininger, Christina Wagner, Rupert Bartsch, Matthias Preusser et al. · 2021 · European Journal of Clinical Investigation
58. Medical Oncology Group of Australia position statement: COVID ‐19 vaccination in patients with solid tumours
    Yada Kanjanapan, Prunella Louise Blinman, Craig R. Underhill, Deme John Karikios, Eva Segelov, Desmond Yip · 2021 · Internal Medicine Journal
59. Age differences in the association of comorbid burden with adverse outcomes in SARS-CoV-2
    A. M. O’Hare, Kristin Berry, Vincent S. Fan, Kristina A. Crothers, McKenna C. Eastment, Jason A. Dominitz, Javeed Ali Shah, P. Green, Emily R. Locke, George N. Ioannou · 2021 · BMC Geriatrics
60. COVID-19 vaccination for cancer patients: Evidence, priority, and practice
    Shiv Rajan, Naseem Akhtar, Sonali Sharma, Deep Chakrabarti, Vijay Kumar · 2021 · Vaccine
61. Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis
    Yang Liu, Shuo Liu, Yujun Qin, Lei Zhao, Yiliang Li, Chenghui Zhou, Wei Chen · 2021 · International Immunopharmacology
62. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
    José Luís Piñana, Lourdes Vázquez, Rodrigo Martino, Rafael de la Cámara, Anna Maria Sureda, Rebeca Rodríguez‐Veiga, Ana Garrido, Jorge Sierra, Josep‐María Ribera, Anna Torrent et al. · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
63. Oncological Care During First Peruvian National Emergency COVID-19 Pandemic: A Multicentric Descriptive Study
    Natalia Valdiviezo, Cindy Alcarraz, Denisse Castro, Renzo Salas, Victor Begazo-Mollo, Marco Galvez-Villanueva, Luz Medina-Aguirre, Elica Garcia-León, Isela Quispe-Santivañez, Carmen Cornejo-Raymundo et al. · 2022 · Cancer Management and Research
64. Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network
    Cathrin Kodde, Marzia Bonsignore, Daniel Schöndube, Torsten Thomas Bauer, Sven Hohenstein, Andreas Bollmann, Andreas Meier‐Hellmann, Ralf Kuhlen, Irit Nachtigall · 2022 · Infection
65. Remission of liquid tumors and SARS-CoV-2 infection: A literature review
    Dong Ho Shin, Andrew Gregg Gillard, Arie Van Wieren, Candelaria Gomez‐Manzano, Juan Fueyo-Margareto · 2022 · Molecular Therapy — Oncolytics
66. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
    Evangelos P. Dimakakos, Georgia Gomatou, M. Catalano, Dan-Mircea Olinic, Alex C. Spyropoulos, Anna Falanga, Anthony Maraveyas, Aaron Liew, Sam Schulman, J. J. F. Belch et al. · 2022 · Anticancer Research
67. Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
    Mayada Abu Shanap, Maher A. Sughayer, Osama A Alsmadi, Ismail Elzayat, Abeer Al Nuirat, Abdelghani Tbakhi, Iyad Yasin Sultan · 2022 · Frontiers in Immunology
68. Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans
    Harshraj Leuva, Mengxi Zhou, Norbert Bräu, Sheldon T. Brown, Prabhjot Singh Mundi, Ta-Chueh Melody Rosenberg, Carol A. Luhrs, Susan Elaine Bates, Yeun‐Hee Anna Park, Tito Fojo · 2022 · Seminars in Oncology
69. Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin
    Margaret B Nolan, Thomas M. Piasecki, Stevens S. Smith, Timothy B. Baker, Michael C. Fiore, Robert T. Adsit, Daniel M. Bolt, Karen L. Conner, Steven L. Bernstein, Oliver D. Eng et al. · 2022 · Cancer Epidemiology Biomarkers & Prevention
70. Comorbidities in the COVID-19 Pandemic: Scopus-Based Bibliometric Analysis
    Yuliya Fedorchenko, Olena Zimba · 2023 · Journal of Korean Medical Science
71. Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience
    Annalisa Trama, Claudia Proto, Jennifer G. Whisenant, Valter Torri, Alessio Cortellini, Olivier Alain Michielin, Fabrice Barlési, Anne‐Marie C. Dingemans, Jan P. van Meerbeeck, Véra Pancaldi et al. · 2020 · Cancer Cell
72. The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study
    Azmaeen Zarif, Mark Joy, Julian Sherlock, James Peter Sheppard, Rachel C. Byford, Oluwafunmi Akinyemi, Clare R Bankhead, Alexandra S. Deeks, Filipa Matos Ferreira, Nicholas Robert Jones et al. · 2021 · Journal of Infection
73. Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report
    Hiroyuki Fujii, Taisuke Tsuji, Mio Sugitani, Yosuke Matsumoto, Tatsuya Yuba, Shunya Tanaka, Yoshifumi Suga, Aosa Matsuyama, Shiho Goda, Ayaka Omura et al. · 2021 · Current Problems in Cancer
74. Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
    Emanuela Romano, Steve Pascolo, Patrick Alexander Ott · 2021 · Journal for ImmunoTherapy of Cancer
75. From SARS-CoV-2 infection to COVID-19 morbidity: an in silico projection of virion flow rates to the lower airway via nasopharyngeal fluid boluses
    S. Basu, Mohammad Mehedi Hasan Akash, Natasha S. Hochberg, Brent Anthony Senior, Diane Joseph‐McCarthy, Arijit Chakravarty · 2022 · Rhinology online
76. The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer
    Anna Rachelle Mislang, Enrique Soto‐Pérez‐de‐Celis, Chiara Russo, Giuseppe A. Colloca, Grant Richard Williams, Shane O’Hanlon, Lisa Cooper, Anita O’Donovan, Riccardo Alberto Audisio, Kwok‐Leung Cheung et al. · 2021 · Journal of Geriatric Oncology
77. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 5)
    David Simons, Lion Shahab, Jamie Brown, Olga Perski · 2020
78. The impact of COVID-19 on hip and knee arthroplasty surgical volume in China
    Zhanqi Wei, Yiming Xu, Bin Feng, Xisheng Weng · 2023 · International Orthopaedics
79. What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study
    Chiara Bellitto, Nicoletta Luxi, Francesco Ciccimarra, Luca L’Abbate, Monika Raethke, Florence P. A. M. van Hunsel, Thomas Lieber, Erik Mulder, Fabio Riefolo, Felipe Villalobos et al. · 2024 · Drug Safety
80. Challenges for cancer care during COVID-19 pandemic in Kenya: Policy implications
    Dinah Kassaman, Rachel Wangari Kimani, Adelaide M. Lusambili · 2020 · Journal of Cancer Policy
81. Healthcare Systems Need to be Organized to Fight two Pandemics Simultaneously
    Partha Sarathi Basu · 2020 · Asian Pacific Journal of Cancer Care
82. Counterbalancing COVID-19 with Cancer Surveillance and Therapy: A Survey of Patients with Renal Cell Carcinoma
    Michael D. Staehler, Dena J. Battle, Sumanta Kumar Pal, Cristiane Decat Bergerot · 2020 · European Urology Focus
83. Randomized Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative
    Gary H. Lyman, Nicole M. Kuderer · 2020 · Cancer Investigation
84. Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations
    Andrew J. Piper‐Vallillo, Meghan J. Mooradian, Catherine Belle Meador, Beow Yong Yeap, Jennifer Peterson, Mustafa Sakhi, Andrew Do, Leyre Zubiri, Sara E. Stevens, Jeanne Vaughn et al. · 2020 · JTO Clinical and Research Reports
85. Challenges of Cancer Immunotherapy during the COVID-19 Pandemic
    Nicole M. Kuderer, Gary H. Lyman · 2020 · Cancer Investigation
86. Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study
    Anna Hardesty, Aakriti Pandita, Kendra Vieira, Ralph Rogers, Basma Merhi, Adena J. Osband, Jad Aridi, Yiyun Shi, George P Bayliss, Christopher J. Cosgrove et al. · 2021 · Transplantation Proceedings
87. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles
    Md. Nazim Uddin, Rehana Akter, Mengyuan Li, Zeinab Abdelrahman · 2021 · Chemico-Biological Interactions
88. Addressing Cancer Survivorship Care Under COVID-19: Perspectives From the Cancer Prevention and Control Research Network
    Cynthia A. Thomson, Linda Overholser, James R. Hébert, Betsy Risendal, Elaine H. Morrato, Stephanie B. Wheeler · 2021 · American Journal of Preventive Medicine
89. Impact of the COVID pandemic on survivors of childhood cancer and survivorship care: lessons for the future
    Maya Prasad, Savita S. Goswami, Jayita K. Deodhar, Girish Chinnaswamy · 2022 · Supportive Care in Cancer
90. Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
    Jessica E. Hawley, Tianyi Sun, David D. Chism, Narjust Duma, Julie C. Fu, Na Tosha Gatson, Sanjay Mishra, Ryan Huu-Tuan Nguyen, Sonya Reid, Oscar Kenneth Serrano et al. · 2022 · JAMA Network Open
91. Impact of the COVID‐19 pandemic on cancer patients and psycho‐oncology providers: Perspectives, observations, and experiences of the American Psychosocial Oncology Society membership
    Natalie Susan McAndrew, Yukino N. Strong, Keayra J. Morris, Timothy S. Sannes, William F. Pirl, Steve W. Cole, Lathika Mohanraj, Jennifer M. Knight · 2022 · Psycho-Oncology
92. Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)
    Sabrina Jotschke, Susann Schulze, Nadja Jaekel, Beatrice Ludwig‐Kraus, Robby Engelmann, Frank Bernhard Kraus, Christina Zahn, Nicole Nedlitz, Gabriele Prange‐Krex, Johannes Mohm et al. · 2022 · Cancers
93. Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer
    Shuying Hu, Feiying Yin, Litao Nie, Yuqin Wang, Jian Qin, Jian Chen · 2022 · Frontiers in Endocrinology
94. Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study
    Sami Akbulut, Tevfik Tolga Şahin, Volkan İnce, Sezai Yılmaz · 2022 · World Journal of Clinical Cases
95. Assessment of SARS-CoV-2 Infection According to Previous Metabolic Status and Its Association with Mortality and Post-Acute COVID-19
    Alejandro de Arriba Fernández, Luis Alonso Bilbao, Alberto Espiñeira Francés, Antonio Cabeza-Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros, Lluís Serra‐Majem · 2022 · Nutrients
96. Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study
    Pietro De Placido, Erica Pietroluongo, Carmine De Angelis, Margherita Tafuro, Chiara Barraco, Rosa Giannatiempo, Roberto Buonaiuto, Francesco Schettini, Anna Iervolino, Emilia Anna Vozzella et al. · 2022 · Frontiers in Oncology
97. Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2
    Limin Wang, Julián Candia, Lichun Ma, Yongmei Zhao, Luisa Imberti, Alessandra Sottini, Eugenia Quirós-Roldán, Kerry Dobbs, Peter D. Burbelo, Jeffrey I. Cohen et al. · 2022 · International Journal of Biological Sciences
98. SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care
    Lindsey Wang, William Jiaen Wang, Rong Xu, Nathan A. Berger · 2022 · Best Practice & Research Clinical Haematology
99. Clinical Informatics Approaches to Understand and Address Cancer Disparities
    Tafadzwa Lawrence Chaunzwa, Maria Quiles del Rey, Danielle S. Bitterman · 2022 · Yearbook of Medical Informatics
100. Molecular signatures in the progression of COVID-19 severity
     Ronika De, Rajeev K. Azad · 2022 · Scientific Reports